Magnesium and Sleep: Types, Dosages, and Evidence
Last reviewed: March 21, 2026, 7:02 a.m.
Magnesium is the fourth most abundant mineral in the human body and serves as a cofactor for over 300 enzymatic reactions, including those involved in neurotransmitter production, nervous system regulation, and the stress response. Despite its importance, an estimated 50% of Americans consume less than the recommended daily amount, and subclinical magnesium deficiency is increasingly recognized as a contributor to poor sleep quality. However, not all magnesium supplements are created equal, and the form of magnesium significantly affects both bioavailability and clinical outcomes.
Magnesium glycinate (or bisglycinate) is generally considered the preferred form for sleep support. In this chelated form, magnesium is bound to the amino acid glycine, which itself has calming properties and has been shown to lower core body temperature and improve subjective sleep quality. The glycinate form is well-absorbed, gentle on the digestive system, and provides the combined benefits of both magnesium and glycine. Typical sleep-supportive doses range from 200 to 400 mg of elemental magnesium, taken 30 to 60 minutes before bed. Magnesium threonate (Magtein) is another form gaining attention, as it has been shown to cross the blood-brain barrier more efficiently, though its specific evidence for sleep is limited compared to glycinate.
The mechanisms by which magnesium may support sleep are multifaceted. Magnesium acts as a natural GABA agonist, binding to GABA-B receptors and enhancing the activity of this primary inhibitory neurotransmitter. It also regulates the stress axis by modulating the hypothalamic-pituitary-adrenal (HPA) axis, potentially reducing cortisol levels that can interfere with sleep onset and maintenance. Additionally, magnesium plays a role in melatonin synthesis by activating tryptophan hydroxylase, the enzyme that converts tryptophan to serotonin, the precursor to melatonin.
Clinical evidence for magnesium and sleep is growing but still moderate in quality. A 2012 randomized, double-blind, placebo-controlled trial in 46 elderly subjects with insomnia found that 500 mg of magnesium daily for 8 weeks was associated with significant improvements in sleep time, sleep efficiency, and melatonin levels compared to placebo. A 2021 systematic review examining multiple studies concluded that magnesium supplementation was associated with improvements in subjective sleep quality, particularly in individuals with poor sleep at baseline, though the authors noted that more large-scale RCTs are needed.
Magnesium may also be relevant for restless leg syndrome (RLS), a condition that significantly disrupts sleep. Some small studies suggest that magnesium supplementation may help reduce RLS symptoms, particularly in cases associated with magnesium deficiency. Forms to avoid for sleep purposes include magnesium oxide (poor bioavailability, primarily useful as a laxative) and magnesium citrate (better absorbed than oxide but more likely to cause gastrointestinal side effects at higher doses). The upper tolerable intake for supplemental magnesium is 350 mg per day for adults, above which diarrhea becomes the primary concern.
Magnesium glycinate (or bisglycinate) is generally considered the preferred form for sleep support. In this chelated form, magnesium is bound to the amino acid glycine, which itself has calming properties and has been shown to lower core body temperature and improve subjective sleep quality. The glycinate form is well-absorbed, gentle on the digestive system, and provides the combined benefits of both magnesium and glycine. Typical sleep-supportive doses range from 200 to 400 mg of elemental magnesium, taken 30 to 60 minutes before bed. Magnesium threonate (Magtein) is another form gaining attention, as it has been shown to cross the blood-brain barrier more efficiently, though its specific evidence for sleep is limited compared to glycinate.
The mechanisms by which magnesium may support sleep are multifaceted. Magnesium acts as a natural GABA agonist, binding to GABA-B receptors and enhancing the activity of this primary inhibitory neurotransmitter. It also regulates the stress axis by modulating the hypothalamic-pituitary-adrenal (HPA) axis, potentially reducing cortisol levels that can interfere with sleep onset and maintenance. Additionally, magnesium plays a role in melatonin synthesis by activating tryptophan hydroxylase, the enzyme that converts tryptophan to serotonin, the precursor to melatonin.
Clinical evidence for magnesium and sleep is growing but still moderate in quality. A 2012 randomized, double-blind, placebo-controlled trial in 46 elderly subjects with insomnia found that 500 mg of magnesium daily for 8 weeks was associated with significant improvements in sleep time, sleep efficiency, and melatonin levels compared to placebo. A 2021 systematic review examining multiple studies concluded that magnesium supplementation was associated with improvements in subjective sleep quality, particularly in individuals with poor sleep at baseline, though the authors noted that more large-scale RCTs are needed.
Magnesium may also be relevant for restless leg syndrome (RLS), a condition that significantly disrupts sleep. Some small studies suggest that magnesium supplementation may help reduce RLS symptoms, particularly in cases associated with magnesium deficiency. Forms to avoid for sleep purposes include magnesium oxide (poor bioavailability, primarily useful as a laxative) and magnesium citrate (better absorbed than oxide but more likely to cause gastrointestinal side effects at higher doses). The upper tolerable intake for supplemental magnesium is 350 mg per day for adults, above which diarrhea becomes the primary concern.